•
Sep 30, 2024

Immunic Q4 2024 Earnings Report

Expected Revenue:$10K
Expected EPS:-$0.23
+54.9% YoY
Total Revenue
$0
0
Gross Profit
-$42K
Previous year: -$23K
+82.6%
Cash and Equivalents
$59.1M
Previous year: $46.7M
+26.6%
Free Cash Flow
-$20.9M
Previous year: -$14.2M
+46.9%
Total Assets
$64.8M
Previous year: $54.3M
+19.3%

Immunic

Immunic